Interview: Charles Grubsztajn – COO, Neopharm Labs, Canada

Speaking about the transformation from a pure service provider to true partner, Charles Grubsztajn of Neopharm Labs in Canada highlights the importance of thinking for clients rather than just with clients. He excitedly shares the aggressive growth period the company is undergoing and how he aims to get a stronger foothold in the US market. Having secured two financial aid packages worth $1.8 million by Canada Economic Development for Québec Regions (CED), how does this set the stage for Neopharm Labs’ development path?
"Most of our clients are Canadian; we have over twenty clients in the US and some clients in Australia, Israel, Brazil, Mexico and other countries."
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Already a member? Sign In

Related Interviews

Latest Report